A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension

Background : Candesartan is a relatively novel antihypertensive agent of the angiotensin receptor blocker (ARB). Several clinical trials have compared candesartan with losartan in the management of essential hypertension. However, systematic assessment of efficacy and safety between candesartan and...

Full description

Bibliographic Details
Main Authors: Zhenfeng Zheng, Huilan Shi, Junya Jia, Dong Li, Shan Lin
Format: Article
Language:English
Published: SAGE Publications 2011-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320310391503